drugset / Trial / NCT03450499

Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section

NCT03450499 ↗

Phase 4 Completed 80 enrolled B.P. Koirala Institute of Health Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo group will receive same amount of normal saline after spinal anesthesia prior to skin incision. Postoperative outcomes measures are total opioid consumption and pain scores for 24 hrs.

Timeline

Start
2018-04-01
Primary completion
2019-03-07
Completion
2019-03-07

Outcome

Met primary endpoint

paper 0 (0-4.67) mg in ketamine group and 1 (0-6) mg in saline group (p=0.003). PMID 34193480 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.25 mg/kg Intravenous

Indications

No indication recorded.